Bausch Health agrees to pay $45 million to settle U.S. charges of misleading disclosures

 Bausch Health agrees to pay $45 million to settle U.S. charges of misleading disclosures
imageEconomy11 hours ago (Jul 31, 2020 04:55PM ET)

WASHINGTON (Reuters) – Canada-based Bausch Health Companies Inc has agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in Securities and Exchange Commission filings and earnings presentations, the SEC said on Friday.

Three former executives, including the chief executive officer of the company, formerly Valeant Pharmaceuticals (NYSE:BHC), also agreed to pay penalties to settle charges against them, the SEC said.

Bausch Health agrees to pay $45 million to settle U.S. charges of misleading disclosures

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Leave a Reply

Your email address will not be published. Required fields are marked *